The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of postoperative serum carcinoembryonic antigen (CEA) with disease-free survival in patients with stage III colon cancer: ACHIEVE phase III randomized clinical trial.
 
Masahito Kotaka
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Dai Manaka
No Relationships to Disclose
 
Tetsuya Eto
No Relationships to Disclose
 
Junichi Hasegawa
Speakers' Bureau - Chugai Pharma; Yakult Honsha
 
Akinori Takagane
No Relationships to Disclose
 
Masato Nakamura
Honoraria - Chugai Pharma; Lilly; Merck; Takeda; Yakult Honsha
 
Takeshi Kato
Honoraria - Asahi Kasei; Bayer; Chugai Pharma; Lilly Japan; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma
 
Yoshinori Munemoto
No Relationships to Disclose
 
Fumitaka Nakamura
No Relationships to Disclose
 
Hiroyuki Bando
No Relationships to Disclose
 
Hiroki Taniguchi
No Relationships to Disclose
 
Makio Gamoh
Honoraria - Asahi Kasei; Bayer Yakuhin; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; Nippon Kayaku; Novartis; Ono Pharmaceutical; Sanofi; Shionogi; Taiho Pharmaceutical; Takeda
Travel, Accommodations, Expenses - Ono Pharmaceutical; Shionogi
 
Manabu Shiozawa
No Relationships to Disclose
 
Masayasu Nishi
No Relationships to Disclose
 
Tetsuya Horiuchi
No Relationships to Disclose
 
Tsunekazu Mizushima
Research Funding - Astellas Pharma (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Lilly Japan (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Takeharu Yamanaka
Honoraria - Bayer; Boehringer Ingelheim; Chugai Pharma
Consulting or Advisory Role - Gilead Sciences; HUYA Bioscience International; Sysmex
Research Funding - Bayer (Inst); Chugai/Roche (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Takayuki Yoshino
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); PAREXEL International Inc. (Inst); Sanofi (Inst); Sumitomo Dainippon (Inst)
 
Atsushi Ohtsu
Employment - Celgene (I)
Honoraria - Chugai Pharma; Ono Yakuhin; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb
 
Masaki Mori
No Relationships to Disclose